Home | Survey | Payment| Talks & Presentations | Job Opportunities
Journals   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
China Prescription Drug
1671-945X
2009 Issue 3
United for Diabetes
pan li
..............page:22
tong ji xue : yi men guan chuan yu lin chuang yan jiu shi zhong de xue ke
zuo xue mei ; mao dong lei
..............page:20
hou ji bao fa rui yi jin qu
liu xuan
..............page:88
fu fang xia tian wu + jia an zuo zuo : zhong xi yi jie he zhi liao lei feng shi guan jie yan de shou xuan pei wu
xue jing ; zhang song zhao ; wang qiao hong ; yang xu yan ; zhu liang ; wen li hong ; wu hua xiang
..............page:85
he zuo du su ke neng de zhen tong ji zhi ji zhen tong zuo yong
yu cui ping ; wang chang du ; an jian xiong ; guo qu lian
..............page:82
man xing shen zang bing de zhong yi yao xun zheng zhi liao
xie xi sheng ; li fei yan ; fan jun ming
..............page:54
Combating the Cons of Consolidation
huang yan
..............page:12
Gearing up for Follow-on Biologics
bethan;hughes; hai yan
..............page:11
A Prenatal Link to Alzheimer 's ?
ron;wins;low; zuo xue mei
..............page:10
Case Report of Endometrial Hyperplasia
gao hui ; yu zuo
..............page:78
Progress in Pathological Diagnosis for Endometrial Hyperplasia
li yang ; wen yong qin ; chen li li
..............page:76
Endometrial Hyperplasia and Endometrial Cancer
yu mei ; zhen ran ; chen rong ; yu zuo
..............page:72
Progress in Hormone Therapy for Endometrial Hyperplasia
liang xiu lan ; ruan xiang yan
..............page:64
Biomarker debate highlights retrospective challenge
dan;jones; liang wei
..............page:62
Progress of EGFR-targeted Therapies in Late-stage Colorectal Cancer
liang hou jie ; zou zuo
..............page:58
Package Insert :Improvement of Safe Medication
song ru liang
..............page:48
Impact of Special NDA on the New Drug R & D in China
wang hai xue ; wang qing li ; hu xiao min
..............page:44
Miracle? A Story of a Doctor from a Small Town
zhong zhen hua
..............page:33
Anti-diabetic Drugs——R & D and Market Competition
huang dong lin
..............page:30